Valneva Se Adr stock is traded at $5.51, with a volume of 7,961. It is down -2.30% in the last 24 hours and down -5.97% over the past month. Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Previous Close:
$5.64
Open:
$5.50
24h Volume:
7,961
Relative Volume:
0.86
Market Cap:
$524.15M
Revenue:
$180.81M
Net Income/Loss:
-$160.71M
P/E Ratio:
-
EPS:
-$1.87
Net Cash Flow:
-$88.46M
1W Performance:
+1.10%
1M Performance:
-5.97%
6M Performance:
+1.85%
1Y Performance:
-38.09%
1-Day Range:
$5.50$5.64
1-Week Range:
$5.31$5.78
52-Week Range:
$4.75$12.18
Valneva Se Adr Stock (VALN) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS